HOTH News and Press, Hoth Therapeutics Inc. From 11/06/19

November 6, 2019 Palm Beach, FL – November 6, 2019 –  Atopic dermatitis is a widespread chronic inflammatory skin condition that can affect patients of all ages and is the result of a complex interplay of environmental, immunological, genetic, and pharmacologic fact...

NEW YORK , Nov. 6, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq:HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as ...

Ultra-thinly traded Hoth Therapeutics ( HOTH +36.3% ) is up on a 5x surge in volume, albeit on turnover of only 51K shares, on no apparent news. More news on: Hoth Therapeutics, Inc., Spherix Incorporated, Healthcare stocks news, Stocks on the move, Read more ...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch to s...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

NEW YORK, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has recently published published CEO Interviews, and conference presentation videos from some of the most talked about stocks today. The CEO Interviews and conference presenta...

Amarin (NASDAQ: AMRN ) resumed with Neutral rating and $17 (10% upside) price target at Goldman Sachs. Shares down a fraction premarket. More news on: Amarin Corporation plc, Amgen Inc., Hoth Therapeutics, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

NEW YORK , Oct. 15, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wo...

NEW YORK , Oct. 14, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wo...

Spherix Incorporated (NASDAQ: SPEX ) approved  (Oct. 2, 2019) a distribution to Spherix stockholders of 0.1M shares of Hoth Therapeutics (NASDAQ: HOTH ) held by Spherix. Spherix stockholder will receive one share of Hoth common stock for every twenty-nine shares of Spherix common sto...